William Lay
Chief Executive Officer en MELODIOL GLOBAL HEALTH LIMITED .
Fortuna: 2 038 $ al 31/03/2024
Perfil
Mr. William Lay is a Chief Executive Officer, Director & MD at Melodiol Global Health Ltd.
and a Group Chief Executive Officer at Creso Pharma US, Inc. He is on the Board of Directors at Melodiol Global Health Ltd.
Mr. Lay was previously employed as an Associate Director by Canopy Growth Corp.
and a Chief Strategy Officer & Executive Vice President by Red Light Holland Corp.
He received his undergraduate degree from Queen's University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/01/2023 | 625 000 ( 0.15% ) | 2 038 $ | 31/03/2024 |
Cargos activos de William Lay
| Empresas | Cargo | Inicio |
|---|---|---|
| MELODIOL GLOBAL HEALTH LIMITED | Chief Executive Officer | 17/01/2022 |
Creso Pharma US, Inc.
 Creso Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Creso Pharma US, Inc. is based in DE. Part of Melodiol Global Health Ltd., Creso Pharma US, Inc. is an American pharmaceutical company. William Lay has been the CEO of the company since 2021. | Chief Executive Officer | 01/01/2022 |
Antiguos cargos conocidos de William Lay.
| Empresas | Cargo | Fin |
|---|---|---|
| CANOPY GROWTH CORPORATION | Corporate Officer/Principal | 01/09/2020 |
| RED LIGHT HOLLAND CORP | Corporate Officer/Principal | - |
Formación de William Lay.
| Queen's University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CANOPY GROWTH CORPORATION | Process Industries |
| RED LIGHT HOLLAND CORP | Process Industries |
| Empresas privadas | 2 |
|---|---|
| Melodiol Global Health Ltd. | |
Creso Pharma US, Inc.
Creso Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Creso Pharma US, Inc. is based in DE. Part of Melodiol Global Health Ltd., Creso Pharma US, Inc. is an American pharmaceutical company. William Lay has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- William Lay
